<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04849156</url>
  </required_header>
  <id_info>
    <org_study_id>1902-LIS-028-SR</org_study_id>
    <nct_id>NCT04849156</nct_id>
  </id_info>
  <brief_title>Spermatozoa Morphology Selection by Thermotaxis</brief_title>
  <official_title>Sperm Selection by Thermotaxis: a Novel Technique to Enhance Assisted Reproductive Technologies' Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidade de Lisboa</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidade de Lisboa</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to eventually assess the usefulness of thermotaxis for sperm selection in&#xD;
      routine clinical practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      As the world's total fertility rate decline, every year more couples require assisted&#xD;
      reproductive technologies (ART) in order to achieve their desire to become parents. However,&#xD;
      these techniques are not guaranteed solutions and still many couples with unexplained&#xD;
      infertility fail to conceive. One of the reasons might be the relative selection of&#xD;
      spermatozoa for the following ART. To minimize a poor selection made by the operator and to&#xD;
      standardize spermatozoa selection, we suggest a new method might be used in combination with&#xD;
      the routine spermatozoa selection techniques.&#xD;
&#xD;
      Thermotaxis might be used in the ART setting as a tool to select the best spermatozoa as&#xD;
      human spermatozoa after capacitation responds positively to a temperature gradient change.&#xD;
      Moreover, this might be the possible navigation mechanism of spermatozoa in the female&#xD;
      genital tract. We hypothesize that spermatozoa selected by thermotaxis behavior might&#xD;
      increase the morphologically normal spermatozoa number in the cohort used during ART.&#xD;
&#xD;
      The aim of this study is to evaluate if thermotaxis is a good method for selecting&#xD;
      morphologically normal sperm for ART.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 12, 2021</start_date>
  <completion_date type="Anticipated">March 5, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 5, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of normal spermatozoa morphology</measure>
    <time_frame>11 months</time_frame>
    <description>Analysis of sperm samples following thermotaxis (intervention) versus the controls (without thermotaxis).</description>
  </primary_outcome>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Male Infertility</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sperm selection by thermotaxis</intervention_name>
    <description>Selection of healthy sperm by thermotaxis procedure</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Sperm samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        10 male sperm donors.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age: ≥18 and &lt;40 years old.&#xD;
&#xD;
          -  Spermatozoa concentration &gt;15 x 10⁶ /mL in all sperm analysis performed in the last 24&#xD;
             months.&#xD;
&#xD;
          -  Spermatozoa mobility &gt;32% in all sperm analysis performed in the last 24 months.&#xD;
&#xD;
          -  Spermatozoa morphology &gt;4% in all sperm analysis performed in the last 24 months.&#xD;
&#xD;
          -  Signed and dated informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of antibiotics, intravenous illicit drugs, chemotherapy or radiotherapy usage in&#xD;
             the last 3 months.&#xD;
&#xD;
          -  Active smoking (during the preceding 12 months).&#xD;
&#xD;
          -  More than 3 days prior to the last ejaculation.&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>39 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Kadir Guleresi, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Valenciano de Infertilidade de Lisboa</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kadir Guleresi, Master</last_name>
    <phone>+351 218 50 32 10</phone>
    <email>kadirguney.guleresi@ivirma.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Samuel Santos-Ribeiro, MD, PhD</last_name>
    <phone>+351 218 50 32 10</phone>
    <email>samuel.ribeiro@ivirma.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Instituto Valenciano de Infertilidade de Lisboa</name>
      <address>
        <city>Lisbon</city>
        <country>Portugal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carla Jorge, PhD</last_name>
      <phone>+351 218 50 32 10</phone>
      <email>carla.jorge@ivirma.com</email>
    </contact>
    <contact_backup>
      <last_name>Samuel Santos-Ribeiro, MD, PhD</last_name>
      <phone>+351 218 50 32 10</phone>
      <email>samuel.ribeiro@ivirma.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Portugal</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 19, 2021</study_first_posted>
  <last_update_submitted>April 13, 2021</last_update_submitted>
  <last_update_submitted_qc>April 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Spermatozoa selection</keyword>
  <keyword>Thermotaxis</keyword>
  <keyword>Testicular and sperm biology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
    <mesh_term>Infertility, Male</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

